US Stock MarketDetailed Quotes

CRGX CARGO Therapeutics

Watchlist
  • 14.900
  • +1.390+10.29%
Close Dec 20 16:00 ET
  • 14.770
  • -0.130-0.87%
Post 20:01 ET
685.81MMarket Cap-4.45P/E (TTM)

CARGO Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
64.09%47.11M
177.13%49.32M
167.63%40.81M
178.13%96.71M
217.64%34.96M
185.71%28.71M
17.8M
15.25M
481.75%34.77M
11.01M
Selling and administrative expenses
72.58%11.18M
206.70%11.86M
283.72%10.3M
287.53%20.92M
344.70%7.89M
310.00%6.48M
--3.87M
--2.69M
256.07%5.4M
--1.77M
-General and administrative expense
72.58%11.18M
206.70%11.86M
283.72%10.3M
287.53%20.92M
344.70%7.89M
310.00%6.48M
--3.87M
--2.69M
256.07%5.4M
--1.77M
Research and development costs
61.62%35.93M
168.92%37.46M
142.82%30.5M
158.03%75.79M
193.22%27.07M
162.52%22.23M
--13.93M
--12.56M
558.44%29.37M
--9.23M
Operating profit
-64.09%-47.11M
-177.13%-49.32M
-167.63%-40.81M
-178.13%-96.71M
-217.64%-34.96M
-185.71%-28.71M
-17.8M
-15.25M
-481.75%-34.77M
-11.01M
Net non-operating interest income expense
504.36%5.4M
762.80%4.99M
433.89%5.01M
67.54%-1.6M
41.77%-1.58M
161.32%894K
578K
-1.5M
-4.94M
-2.71M
Non-operating interest income
504.36%5.4M
762.80%4.99M
4,666.67%5.01M
----
----
--894K
--578K
--105K
----
----
Non-operating interest expense
--0
--0
--0
-67.54%1.6M
--0
--0
--0
--1.6M
--4.94M
--2.71M
Other net income (expense)
97.40%-199K
97.32%-17K
-100.25%-10K
113.49%167K
12,477.78%4.46M
-883.80%-7.65M
-634K
4M
-1,074.80%-1.24M
-36K
Gain on sale of security
----
----
----
630.67%6.45M
--0
----
----
--6.45M
---1.22M
---30K
Special income (charges)
--0
--0
--0
---2.32M
--0
--0
--0
---2.32M
--0
--0
-Less:Other special charges
----
----
----
--2.32M
--0
----
----
--2.32M
----
----
Other non- operating income (expenses)
97.40%-199K
97.32%-17K
92.75%-10K
-17,945.45%-3.97M
74,366.67%4.46M
-765,500.00%-7.65M
---634K
---138K
-117.32%-22K
---6K
Income before tax
-18.15%-41.91M
-148.42%-44.35M
-180.94%-35.81M
-139.67%-98.15M
-133.30%-32.08M
-188.73%-35.47M
-17.85M
-12.75M
-600.02%-40.95M
-13.75M
Income tax
Net income
-18.15%-41.91M
-148.42%-44.35M
-180.94%-35.81M
-139.67%-98.15M
-133.30%-32.08M
-188.73%-35.47M
-17.85M
-12.75M
-600.02%-40.95M
-13.75M
Net income continuous Operations
-18.15%-41.91M
-148.42%-44.35M
-180.94%-35.81M
-139.67%-98.15M
-133.30%-32.08M
-188.73%-35.47M
---17.85M
---12.75M
-600.02%-40.95M
---13.75M
Minority interest income
Net income attributable to the parent company
-18.15%-41.91M
-148.42%-44.35M
-180.94%-35.81M
-139.67%-98.15M
-133.30%-32.08M
-188.73%-35.47M
-17.85M
-12.75M
-600.02%-40.95M
-13.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-18.15%-41.91M
-148.42%-44.35M
-180.94%-35.81M
-139.67%-98.15M
-133.30%-32.08M
-188.73%-35.47M
-17.85M
-12.75M
-600.02%-40.95M
-13.75M
Basic earnings per share
4.06%-0.88
-120.96%-1.02
-163.95%-0.87
-685.96%-16.53
-10.25%-0.7785
-45.37%-0.9172
-0.4616
-0.3296
-600.02%-2.1032
-0.7061
Diluted earnings per share
4.06%-0.88
-120.96%-1.02
-163.95%-0.87
-685.96%-16.53
-10.25%-0.7785
-45.37%-0.9172
-0.4616
-0.3296
-600.02%-2.1032
-0.7061
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 64.09%47.11M177.13%49.32M167.63%40.81M178.13%96.71M217.64%34.96M185.71%28.71M17.8M15.25M481.75%34.77M11.01M
Selling and administrative expenses 72.58%11.18M206.70%11.86M283.72%10.3M287.53%20.92M344.70%7.89M310.00%6.48M--3.87M--2.69M256.07%5.4M--1.77M
-General and administrative expense 72.58%11.18M206.70%11.86M283.72%10.3M287.53%20.92M344.70%7.89M310.00%6.48M--3.87M--2.69M256.07%5.4M--1.77M
Research and development costs 61.62%35.93M168.92%37.46M142.82%30.5M158.03%75.79M193.22%27.07M162.52%22.23M--13.93M--12.56M558.44%29.37M--9.23M
Operating profit -64.09%-47.11M-177.13%-49.32M-167.63%-40.81M-178.13%-96.71M-217.64%-34.96M-185.71%-28.71M-17.8M-15.25M-481.75%-34.77M-11.01M
Net non-operating interest income expense 504.36%5.4M762.80%4.99M433.89%5.01M67.54%-1.6M41.77%-1.58M161.32%894K578K-1.5M-4.94M-2.71M
Non-operating interest income 504.36%5.4M762.80%4.99M4,666.67%5.01M----------894K--578K--105K--------
Non-operating interest expense --0--0--0-67.54%1.6M--0--0--0--1.6M--4.94M--2.71M
Other net income (expense) 97.40%-199K97.32%-17K-100.25%-10K113.49%167K12,477.78%4.46M-883.80%-7.65M-634K4M-1,074.80%-1.24M-36K
Gain on sale of security ------------630.67%6.45M--0----------6.45M---1.22M---30K
Special income (charges) --0--0--0---2.32M--0--0--0---2.32M--0--0
-Less:Other special charges --------------2.32M--0----------2.32M--------
Other non- operating income (expenses) 97.40%-199K97.32%-17K92.75%-10K-17,945.45%-3.97M74,366.67%4.46M-765,500.00%-7.65M---634K---138K-117.32%-22K---6K
Income before tax -18.15%-41.91M-148.42%-44.35M-180.94%-35.81M-139.67%-98.15M-133.30%-32.08M-188.73%-35.47M-17.85M-12.75M-600.02%-40.95M-13.75M
Income tax
Net income -18.15%-41.91M-148.42%-44.35M-180.94%-35.81M-139.67%-98.15M-133.30%-32.08M-188.73%-35.47M-17.85M-12.75M-600.02%-40.95M-13.75M
Net income continuous Operations -18.15%-41.91M-148.42%-44.35M-180.94%-35.81M-139.67%-98.15M-133.30%-32.08M-188.73%-35.47M---17.85M---12.75M-600.02%-40.95M---13.75M
Minority interest income
Net income attributable to the parent company -18.15%-41.91M-148.42%-44.35M-180.94%-35.81M-139.67%-98.15M-133.30%-32.08M-188.73%-35.47M-17.85M-12.75M-600.02%-40.95M-13.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -18.15%-41.91M-148.42%-44.35M-180.94%-35.81M-139.67%-98.15M-133.30%-32.08M-188.73%-35.47M-17.85M-12.75M-600.02%-40.95M-13.75M
Basic earnings per share 4.06%-0.88-120.96%-1.02-163.95%-0.87-685.96%-16.53-10.25%-0.7785-45.37%-0.9172-0.4616-0.3296-600.02%-2.1032-0.7061
Diluted earnings per share 4.06%-0.88-120.96%-1.02-163.95%-0.87-685.96%-16.53-10.25%-0.7785-45.37%-0.9172-0.4616-0.3296-600.02%-2.1032-0.7061
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data